Valuation (53%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 12.54 | 41.38 |
PEG Ratio (TTM) | 0.07 | 2.02 |
P/S Ratio (TTM) | 19.47 | 46.69 |
P/B Ratio (TTM) | 0.98 | 0.97 |
P/FCF Ratio (TTM) | N/A | 13.99 |
Price to 5YR AVG Earnings Ratio | 38.02 | 27.87 |
Price to 5YR AVG FCF Ratio | N/A | 26.98 |
Profitability (55%) |
Company | Industry |
---|---|---|
ROA (TTM) | 7.71% | 2.93% |
ROE (TTM) | 8.01% | 7.46% |
Net Profit Margin (TTM) | 155.22% | 18.31% |
ROIC 5YR AVG | 4.11% | 8.21% |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 31.60% | 236.69% | 147.60% |
Revenue | -4.58% | 186.78% | 113.36% |
Net Income | 32.95% | 238.93% | 148.83% |
Cash Flow | N/A | N/A | N/A |
Health (53%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.63 | 2.32 |
Quick Ratio (TTM) | 2.63 | 2.27 |
D/E Ratio (TTM) | N/A | 0.73 |
Interest Coverage (TTM) | N/A | 13.29 |
Piotroski F-Score | 4 | 6 |
Altman Z-Score | 64.59 | 8.05 |
LTL to 5YR AVG FCF | N/A | 8.96 |
Shares Outstanding Growth 5YR AVG | 0.01% | -2.68% |